QLT0074

· QLT Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QLT0074, covering 2012-05-23 to 2012-05-23. Get the full timeline:

Most recent: Clinical Trial Update: Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia [Phase 1, Phase 2]